This month’s selection reflects the remarkable momentum in the pulmonary hypertension field — from landmark regulatory approvals and cutting-edge research to inspiring human stories and practical tools for patients. As always, we have curated a range of content to inform, inspire, and empower our community.
RESEARCH AND SCIENCE
- Sotatercept approved in England and Wales by the National Institute for Health and Care Excellence (NICE), May 14, 2026
- Efficacy and safety of sotatercept in patients with pulmonary arterial hypertension associated with connective tissue disease, ATS International Conference, May 18, 2026
- Scientific review of current and emerging signalling pathways in pulmonary arterial hypertension, Current Opinions in Pulmonary Medicine, May 5, 2026
- Thirty Years of Progress in Pulmonary Arterial Hypertension Treatment: From Despair to Hope, Chinese Medical Journal, May 19, 2026
- New study aims to see how triple combination therapy with sotatercept affects pulmonary vascular resistance in newly diagnosed pulmonary arterial hypertension patients
- Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed — not a new article but still highly relevant today, ERS Editorial
INDUSTRY NEWS
- United Therapeutics presents positive data from ongoing research at the American Thoracic Society’s International Conference, May 15–20, Orlando
- CalciMedica advances novel oral therapy for pulmonary hypertension, PR Newswire, May 12, 2026
- Tenax Therapeutics reports progress on an investigational drug for WHO Group 2 pulmonary hypertension, BioSpace, May 12, 2026
- South Korean biotech GI Innovation files patent for next-generation pulmonary arterial hypertension candidate, The Bio, April 29, 2026
DIGITAL HEALTH AND INNOVATION
- AI imaging company Qureight brings together leading pulmonary hypertension experts on new Scientific Advisory Board, Biospace, May 5, 2026
- Flexible, Accessible, Effective: Patient Perceptions of the Pulmonary Hypertension and Home-Based (PHAHB) Physical Activity Intervention, Pulmonary Circulation, April 29, 2026
- Remote exercise assessment in pulmonary hypertension, Current Opinions in Pulmonary Medicine, May 7, 2026
TRANSPLANT
- Lung Transplant Recipient Reaches Record High Altitude on Mount Aconcagua (6,961 m) during a scientific expedition, Transplant International, May 12, 2026
- “Transplantation Roadmap: Understanding the Role of Risk Assessment in Your Pulmonary Hypertension Plan” — webinar, June 2, 2026, 3 p.m. EDT
- Progress on xenotransplantation and bioengineered organs — the potential next growth frontier for United Therapeutics
PATIENT ADVOCACY
- Cereno Scientific announces partnership with PHA Europe on patient-centred pulmonary hypertension drug design, May 11, 2026
- When breath becomes music: a campaign to pay tribute to persons living with pulmonary arterial hypertension, World Pulmonary Hypertension Day, May 5, 2026
ECONOMIC IMPACT
- Economic burden of pulmonary arterial hypertension in Switzerland, Plos One, April 28, 2026